Concepedia
Statistics
Publications
10
Citations
241
H-Index
Active since
1975
Affiliations
Avon (United States)(Current)
Clinical Research Associates
Fox Chase Cancer Center
United States Food and Drug Administration
Bristol-Myers Squibb (United States)
Michael S. Dickens is an author at Avon (United States) specializing in toxicology, pharmacy, and medicine.
Publications per year
1975–1998
Evaluation of the EpiOcularTM Tissue Model as an Alternative to the Draize Eye Irritation Test
Michael E. Stern, Mitchell Klausner, Raquel Alvarado et al. · Toxicology in Vitro · 1998 · 69 citations
Medicine, Ophthalmology, Pharmacology +8
Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture.
Michael S. Dickens, R P Custer, S Sorof · Proceedings of the National Academy of Sciences · 1979 · 52 citations · Full text
Medicine, Cancer Biology, Oncology +16
Retinoid prevents transformation of cultured mammary glands by procarcinogens but not by many activated carcinogens
Michael S. Dickens, Sam Sorof · Nature · 1980 · 24 citations
Medicine, Cancer Biology, Oncology +14
Report of the Validation and Technology Transfer committee of the Johns Hopkins Center for Alternatives to Animal Testing Framework for validation and implementation of<i>in vitro</i>toxicity tests
Alan M. Goldberg, John M. Frazier, David Brusick et al. · Xenobiotica · 1993 · 17 citations
Pharmacy, Toxicology, Good Laboratory Practice +13
Multiple Computer Automated Structure Evaluation Methodology as an Alternative to <i>In Vivo</i> Eye Irritation Testing
Gilles Klopman, Dmitri Ptchelintsev, Manton R. Frierson et al. · Alternatives to Laboratory Animals · 1993 · 17 citations
Pharmacy, Ophthalmology, Toxicology +14
1–5 of 10